Reproducibility of nasal allergen challenge in evaluating the efficacy of intranasal corticosteroid treatment

Clinical and Experimental Allergy

Volumn 40, Issue 5, 2010, Pages 738-744

  Proud, D ^a   Riker, D K ^b   Togias, A ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b On Point Advisors   (United States)

Author keywords

Albumin; Allergic rhinitis; Corticosteroids; Glandular secretion; Kinins; Lavage; Lysozyme; Nasal challenge; Vascular permeability

Indexed keywords

ALBUMIN; ALLERGEN; BECLOMETASONE; CORTICOSTEROID; KININ; LYSOZYME;

ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HAY FEVER; HUMAN; POLLEN; PRIORITY JOURNAL; PROVOCATION TEST; RAGWEED; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SKIN TEST; SNEEZING; SYMPTOM;

ADMINISTRATION, INTRANASAL; ADULT; ALBUMINS; ALLERGENS; AMBROSIA; ANTI-ASTHMATIC AGENTS; BECLOMETHASONE; CLINICAL TRIALS AS TOPIC; FEMALE; GLUCOCORTICOIDS; HUMANS; KININS; MALE; MURAMIDASE; NASAL LAVAGE FLUID; NASAL PROVOCATION TESTS; POACEAE; REPRODUCIBILITY OF RESULTS; RHINITIS, ALLERGIC, SEASONAL; SNEEZING; TREATMENT OUTCOME;

EID: 77950947899     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03466.x     Document Type: Article

References (28)

1. Akerlund A, Andersson M, Leflein J, Lildholdt T, Mygind N. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. J Allergy Clin Immunol 2005 115 : S460 82.
2. Togias A, Corren J, Wagenmann M. Nasal provocation testing. In : Adkinson NF Jr., Busse WW, Bochner BS, Holgate ST, Lemanske RF Jr., Simons FER, eds. Middleton's allergy principles and practice, 7th Edn. Maryland Heights, MO, USA: Elsevier Inc., 2009 1281 1294.
3. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990 142 : 167 171.
4. Naclerio RM, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM. The effect of cetirizine on the early allergic response. Laryngoscope 1989 99 : 596 599.
5. Corren J, Rachelefsky G, Spector S et al. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions. J Allergy Clin Immunol 1999 103 : 574 580.
6. Baroody FM, Lim MC, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg 1996 122 : 309 316.
7. Pipkorn P, Costantini C, Reynolds CJ et al. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation. Ann Allergy Asthma Immunol 2008 101 : 82 9.
8. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987 316 : 1506 1510. (Pubitemid 17076234)
9. Andersson M, Andersson P, Pipkorn U. Allergen-induced specific and non-specific nasal reactions: reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolarngol 1989 107 : 270 277.
10. Creticos PS, Adkinson NF Jr., Kagey-Sobotka A et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest 1985 76 : 2247 2253 (published erratum appears in J Clin Invest November 1986; 78:1421).
11. Iliopoulos O, Proud D, Adkinson NF Jr. et al. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991 87 : 855 866.
12. Corren J, Diaz-Sanchez D, Saxon A et al. Effects of omalizumab, a humanized monoclonal anti-Ige antibody, on nasal reactivity to allergen and local IgE synthesis. Ann Allergy Asthma Immunol 2004 93 : 243 248.
13. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhinition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. New Engl J Med 1987 316 : 1506 1510.
14. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983 72 : 1678 1685.
15. Raphael GD, Igarashi Y, White MV, Kaliner MA. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions. J Allergy Clin Immunol 1991 88 : 33 42.
16. Raphael GD, Jeney EV, Baraniuk JN, Kim I, Meredith SD, Kaliner MA. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J Clin Invest 1989 84 : 1528 1535.
17. Proud D, Kaplan AP. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988 6 : 49 83.
18. Proud D, Reynolds CJ, LaCapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988 137 : 613 616.
19. Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol 1996 97 : 1252 1263.
20. Riccio MM, Reynolds CJ, Hay DW, Proud D. Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am J Respir Crit Care Med 1995 152 : 1757 1764.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 : 307 310.
22. Day JH, Ellis AK, Rafeiro E, Ratz JD, Briscoe MP. Experimental models for the evaluation of treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2006 96 : 263 278.
23. Greiff L, Persson CG, Andersson M. Desloratidine reduces allergen challange-induced mucinous secretion and plasma exudation in allergic rhinitis. Ann Allergy Asthma Immunol 2002 89 : 413 418.
24. Proud D, Reynolds CJ, Lichtenstein LM, Kagey-Sobotka A, Togias A. Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 1998 28 : 868 875.
25. Emanuelsson CA, Andersson M, Persson CGA, Thorsson L, Greiff L. Effects of topical formoteral alone and in combination with budesonide in a pollen season model of allergic rhinitis. Respir Med 2007 101 : 1106 1112.
26. Baroody FM, Wagenmann M, Naclerio RM. Comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol 1993 74 : 2661 2671.
27. Majchel AM, Proud D, Freidhoff L, Creticos PS, Norman PS, Naclerio RM. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol 1992 90 : 85 91.
28. Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol 1992 90 : 373 376.